High Level of PTEN Expression Is Associated with Low-grade Liver Metastasis and Satisfactory Patient Survival in Pancreatic Cancer

Archives of Medical Research

Volumn 42, Issue 7, 2011, Pages 584-588

  Feng, Chao ^a   Yao, Ruoquan ^a   Huang, Feizhou ^a   Liu, Xunyang ^a   Nie, Wanpin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Liver metastasis; Pancreatic cancer; Phosphatase and tensin homolog

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PATHOLOGY; PROTEIN EXPRESSION;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; SURVIVAL RATE;

EID: 84862968354     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.10.008     Document Type: Article

References (25)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin 2009, 59:225-249.
2. Bao B., Ali S., Kong D., et al. Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. PLoS One 2011, 6:e17850.
3. Thomas G.V., Horvath S., Smith B.L., et al. Antibody-based profiling of the phosphoinositide 3-kinase pathway in clinical prostate cancer. Clin Cancer Res 2004, 10:8351-8356.
4. Stoll V., Calleja V., Vassaux G., et al. Dominant negative inhibitors of signaling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer. Gut 2005, 54:109-116.
5. Cully M., You H., Levine A.J., et al. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 2006, 6:184-192.
6. Chow J.Y., Ban M., Wu H.L., et al. TGF-beta downregulates PTEN via activation of NF-kappaB in pancreatic cancer cells. Am J Physiol Gastrointest Liver Physiol 2010, 298:G275-G282.
7. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998, 273:13375-13378.
8. Di Cristofano A., Pandolfi P.P. The multiple roles of PTEN in tumor suppression. Cell 2000, 100:387-390.
9. Simpson L., Parsons R. PTEN: life as a tumor suppressor. Exp Cell Res 2001, 264:29-41.
10. Okami K., Wu L., Riggins G., et al. Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. Cancer Res 1998, 58:509-511.
11. Chow J.Y., Quach K.T., Cabrera B.L., et al. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells. Carcinogenesis 2007, 28:2321-2327.
12. Hill R., Calvopina J.H., Kim C., et al. PTEN loss accelerates KrasG12D-induced pancreatic cancer development. Cancer Res 2010, 70:7114-7124.
13. Safioleas M.C., Moulakakis K.G. Pancreatic cancer today. Hepatogastroenterology 2004, 51:862-868.
14. Saleem A., Jackson A., Mukherjee S., et al. Radiotherapy in the management of unresectable locally advanced pancreatic cancer: a survey of the current UK practice of clinical oncologists. Clin Oncol (R Coll Radiol) 2010, 22:257-260.
15. Sener S.F., Fremgen A., Menck H.R., et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999, 189:1-7.
16. Tamura M., Gu J., Matsumoto K., et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998, 280:1614-1617.
17. Bunney T.D., Katan M. Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer 2010, 10:342-352.
18. Sawai H., Yasuda A., Ochi N., et al. Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterol 2008, 8:56.
19. Burgering B.M., Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995, 376:599-602.
20. Jones R.G., Saibil S.D., Pun J.M., et al. NF-kappaB couples protein kinase B/Akt signaling to distinct survival pathways and the regulation of lymphocyte homeostasis invivo. J Immunol 2005, 175:3790-3799.
21. Chow J.Y., Dong H., Quach K.T., et al. TGF-beta mediates PTEN suppression and cell motility through calcium-dependent PKC-alpha activation in pancreatic cancer cells. Am J Physiol Gastrointest Liver Physiol 2008, 294:G899-G905.
22. Ma J., Sawai H., Ochi N., et al. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Mol Cell Biochem 2009, 331:161-171.
23. Eng C. PTEN: one gene, many syndromes. Hum Mutat 2003, 22:183-198.
24. Bai M.H., Ma H.B., Wang X.J. Effects of activated PPARgamma on the expression of PTEN gene in pancreatic cancer cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2008, 24:717-720.
25. Tao J., Xiong J., Li T. Correlation between protein expression of PTEN in human pancreatic cancer and the proliferation, infiltration, metastasis and prognosis. J Huazhong Univ Sci Technolog Med Sci 2006, 26:444-447.